A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 1, 2009, Pages 29-36

  Chou, Tsui Wei ^a,b   Ma, Chien Ya ^b   Cheng, Hsing Hsien ^b   Chen, Ya Yen ^b   Lai, Ming Hoang ^a  

^a KAINAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

oryzanol; tocotrienol; Insulin resistance; Rice bran oil; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID; FATTY ACID; GAMMA ORYZANOL; GAMMA TOCOTRIENOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NICOTINAMIDE; RICE BRAN OIL; SOYBEAN OIL; STEROL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FECES; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIPID METABOLISM; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

GLYCINE MAX; RATTUS;

EID: 67849111442     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.08-257     Document Type: Article

References (51)

1. King, H., Aubert, R.E., and Herman, W.H.: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431, 1998.
2. Uusitupa, M., Siitonen, O., Aro, A., and Pyorala, K.: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged newly diagnosed Type 2 (non-insulindependent) diabetic subjects. Diabetologia, 28, 22-27, 1985. (Pubitemid 15155990)
3. Haffner, S.M., Lehto, S., Rönnemaa, T., Pyörälä, K., and Laakso, M.: Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl. J. Med., 339, 229-234, 1998.
4. Turner, R.C., Millns, H., Neil, H.A.W., Stratton, I.M., Manley, S.E., Matthews, D.R., and Holman, R.R.: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). B.M.J., 316, 823-828, 1998.
5. Betteridge, J., Colhoun, H., and Armitage, J.: Status report of lipid lowering trials in diabetes. Curr. Opin. Lipidology, 11, 621-626, 2000.
6. Ginsberg, H.N.: Insulin resistance and cardiovascular disease. J. Clin. Invest., 106, 453-458, 2000.
7. Rivellese, A.A. and Lilli, S.: Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed. Pharmacother., 57, 84-87, 2003.
8. Wilson, T.A., Ausman, L.M., Lawton, C.W., Hegsted, D.M., and Nicolosi, R.J.: Comparative cholesterol lowering propertiesof vegetable oils: Beyond fatty acids. J. Am. Coll. Nutr., 19, 601-607, 2000.
9. Cicero, A.F. and Gaddi, A.: Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother. Res., 15, 277-289, 2001.
10. Berger, A., Rein, D., Schafer, A., Monnard, I., Gremaud, G., Lambelet, P., and Bertoli, C.: Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur. J. Nutr., 43, 1-11, 2004.
11. Rukmini, C. and Raghuram, T.C.: Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review. J. Am. Coll. Nutr., 10, 593-601, 1991.
12. Sunitha, T.R. and Rukmini, C.: Lipid profile of rats fed blends of rice bran oil in combination with sunflower and safflower oil. Plant Foods Hum. Nutr., 51, 219-230, 1997.
13. Qureshi, A.A., Sami, S.A., and Khan, F.A.: Effects of stabilized rice bran, its soluble and fiber fractions on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II. J. Nutr. Biochem., 13, 175-187, 2002.
14. Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys, D., Novelli, M., and Ribes, G.: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47, 224-229, 1998. (Pubitemid 28079978)
15. Reeves, P.G., Nielsen, F.H., and Fahey, G.C. Jr.: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr., 123, 1939-1951, 1993.
16. 2 extract of Elettaria cardamomum (L.) Maton. J. Agric. Food Chem., 52, 6278-6282, 2004.
17. National Academy of Sciences: Guide for the care and use of laboratory animals. Washington, D.C., USA, 21-48, 1996.
18. Qureshi, A.A., Mo, H., Packer, L., and Peterson, D.M.: Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J. Agric. Food Chem., 48, 3130-3140, 2000.
19. Lepage, G. and Roy, C.C.: Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res., 27, 1114-1120, 1986. (Pubitemid 16045295)
20. Folch, J., Lees, M., and Sloane-Stanley, G.H.: A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509, 1957.
21. Mashige, F., Tanaka, N., Maki, A., Kamei, S., and Yamanaka, M.: Direct spectrophotometry of total bile acids in serum. Clin. Chem., 27, 1352-1356, 1981.
22. Cortez, M.Y., Torgan, C.E., Brozinick, J.T. Jr., and Ivy, J.L.: Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am. J. Physiol., 261, 613-619, 1991.
23. Shafrir, E.: Diabetes in animals, in Diabetes Mellitus: Theory and Practice, eds. By Rifkin, H. and Porte, D. Jr., Elsevier, New York, NY, pp. 299-340, 1990.
24. Bonner-Weir, S., Trent, D.F., and Weir, G.C.: Partial pancreatectomy in the rat and subsequent defect in glucoseinduced insulin release. J. Clin. Invest., 71, 1544-1553, 1983.
25. Weir, G.C., Leahy, J.L., and Bonner-Weir, S.: Experimental reduction of beta-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab. Rev., 2, 125-161, 1986.
26. Portha, B., Blondel, O., Serradas, P., McEvoy, R., Giroix, M.H., Kergoat, M., and Bailbe, D.: The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab., 15, 61-75, 1989. (Pubitemid 19140020)
27. Stefan, I., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y., and Unger, R.H.: Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes, 31, 694-700, 1982.
28. Kloppel, G., Lohr, M., Hablich, K., Oberholzer, M., and Heitz, P.U.: Islet pathology and pathogenesis of type I and type II diabetes revisited. Surv. Synth. Pathol. Res., 4, 110-125, 1985.
29. Movassat, J., Saulner, C., and Portha, B.: Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus. Diabetes Metab., 21, 365-370, 1995. (Pubitemid 26018858)
30. Weir, G.C., Clore, E.T., Zmachinski, C.J., and Bonner-Weir, S.: Islet secretion in a new experimental model for non-insulin-dependent-diabetes. Diabetes, 30, 590-595, 1981.
31. Giroix, M.H., Vesco, L., and Portha, B.: Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model on noninsulin-dependent diabetes. Endocrinology, 132, 815-822, 1993. (Pubitemid 23056144)
32. Sasaki, J., Takada, Y., Handa, K., Kusuda, M., Tanabe, Y., Matsunaga, A., and Arakawa, K.: Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin. Ther., 12, 263-268, 1990.
33. Purushothama, S., Raina, P.L., and Hariharan, K.: Effect of long-term feeding of rice bran oil upon lipids and lipoproteins in rats. Mol. Cell Biochem., 146, 63-69, 1995.
34. Vissers, M.N., Zock, P.L., Meijer, G.W., and Katan, M.B.: Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans. Am. J. Clin. Nutr., 72, 1510-1515, 2000.
35. Lim, S.Y., Doherty, J.D., and Salem, N. Jr.: Lead exposure and (n-3) fatty acid deficiency during rat neonatal development alter liver, plasma, and brain polyunsaturated fatty acid composition. J. Nutr., 135, 1027-1033, 2005.
36. Brynes, A.E., Edwards, C.M., Jadhav, A., Ghatei, M.A., Bloom, S.R., and Frost, G.S.: Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am. J. Clin. Nutr., 72, 1111-1118, 2007.
37. Sharma, R.D. and Rukmini, C.: Hypocholesterolemic activity of unsaponifiable matter of rice bran oil. Indian J. Med. Res., 85, 178-281, 1987.
38. Ridker, P.M., Rifai, N., Cook, N.R., Bradwin, G., and Buring, J.E.: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. J.A.M.A., 294, 326-333, 2005. (Pubitemid 41043776)
39. Ridker, P.M., Rifai, N., Cook, N.R., Bradwin, G., and Buring, J.E.: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. J.A.M.A., 294, 326-333, 2005. (Pubitemid 41043776)
40. Tabata, T., Tanaka, M., and Iio, T.: Hypocholesterolemic activity of phytosterol. Yakugaku Zasshi, 100, 546-552, 1980.
41. Shefer, S., Hauser, S., Lapar, V., and Mosbach, E.H.: Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7alpha-hydroxylase in the rat. J. Lipid Res., 14, 573-580, 1973.
42. Li, Y., Hou, M.J., Ma, J., Tang, Z.H., Zhu, H.L., and Ling, W.H.: Dietary fatty acids regulate cholesterol induction of liver CYP7alpha1 expression and bile acid production. Lipids, 40, 455-462, 2005. (Pubitemid 40911445)
43. Rong, N., Ausman, L.M., and Nicolosi, R.J.: Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids, 32, 303-309, 1997. (Pubitemid 27131763)
44. Bloomgarden, Z.T.: Cardiovascular disease and diabetes. Diabetes Care, 26, 230-237, 2003.
45. Levine, R. and Haft, D.E.: Carbohydrate homeostasis. N. Engl. J. Med, 283, 237-246, 1970.
46. Chen, C.W. and Cheng, H.H.: A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J. Nutr., 136, 1472-1476, 2006.
47. Parillo, M., Rivellese, A.A., Ciardullo, A.V., Capaldo, B., Giacco, A., Genovese, S., and Riccardi, G.: A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism, 41, 1373-1378, 1992. (Pubitemid 23001578)
48. Ryysy, L., Häkkinen, A.M., Goto, T., Vehkavaara, S., Westerbacka, J., Jalavaara, J., and Yki-Järvinen, H.: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes, 49, 749-758, 2000. (Pubitemid 30339990)
49. Ginsberg, H.N., Zhang, Y.L., and Hernandez-Ono, A.: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res., 36, 232-240, 2005.
50. Groop, L., Widen, E., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Schalin, C., and Eriksson, J.: Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 32, 599-605, 1989. (Pubitemid 19215442)
51. McGarry, J.D.: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes, 51, 7-18, 2001.